Rapport Therapeutics, Inc. (RAPP) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $484.65M | +58.7% |
| 2024 | $305.43M | +1291.5% |
| 2023 | -$25.63M | -154.8% |
| 2022 | -$10.06M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $484.65M | +58.7% |
| 2024 | $305.43M | +1291.5% |
| 2023 | -$25.63M | -154.8% |
| 2022 | -$10.06M | — |